Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

GeoVax Labs (GOVX) 10K Form and Latest SEC Filings 2026

GeoVax Labs logo
$2.01 -0.20 (-9.05%)
Closing price 05/19/2026 04:00 PM Eastern
Extended Trading
$2.00 -0.01 (-0.75%)
As of 05/19/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest GeoVax Labs SEC Filings & Recent Activity

GeoVax Labs (NASDAQ:GOVX) has submitted 324+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form 8-K submitted on May 19, 2026.

8-K
GeoVax Labs Files Current Report on May. 19, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-K
GeoVax Labs Files Annual Report on Apr. 15, 2026

The 10-K contains GeoVax Labs's audited financial statements, revenue, earnings, and risk factors for the prior fiscal year.

View earnings history

GeoVax Labs SEC Filing History

Browse GeoVax Labs' complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/19/2026 4:04 PM
GeoVax Labs (832489) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2026 10:19 AM
ARMISTICE CAPITAL, LLC (1601086) Filed by
GeoVax Labs (832489) Subject
Form SCHEDULE 13G/A
04/21/2026 11:15 PM
GeoVax Labs (832489) Filer
Form EFFECT
04/21/2026 11:15 PM
GeoVax Labs (832489) Filer
Form EFFECT
04/19/2026 11:15 PM
GeoVax Labs (832489) Filer
Form EFFECT
04/19/2026 11:15 PM
GeoVax Labs (832489) Filer
Form EFFECT
04/19/2026 11:15 PM
GeoVax Labs (832489) Filer
Form EFFECT
04/19/2026 11:15 PM
GeoVax Labs (832489) Filer
Form EFFECT
04/19/2026 11:15 PM
GeoVax Labs (832489) Filer
Form EFFECT
04/17/2026 8:04 AM
GeoVax Labs (832489) Filer
Form POS EX
04/17/2026 8:04 AM
GeoVax Labs (832489) Filer
Form POS EX
04/17/2026 8:04 AM
GeoVax Labs (832489) Filer
Form POS EX
04/17/2026 8:04 AM
GeoVax Labs (832489) Filer
Form POS EX
04/17/2026 8:05 AM
GeoVax Labs (832489) Filer
Form POS EX
04/16/2026 3:15 PM
GeoVax Labs (832489) Filer
Form PRE 14A
04/15/2026 4:20 PM
GeoVax Labs (832489) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2026 2:57 PM
GeoVax Labs (832489) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/31/2026 4:15 PM
GeoVax Labs (832489) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2026 3:55 PM
GeoVax Labs (832489) Filer
Form NT 10-K
02/17/2026 8:45 PM
ARMISTICE CAPITAL, LLC (1601086) Filed by
GeoVax Labs (832489) Subject
Form SCHEDULE 13G/A
02/17/2026 9:33 AM
GeoVax Labs (832489) Filer
Form 424B5
02/17/2026 7:00 AM
GeoVax Labs (832489) Subject
L1 Capital Global Opportunities Master Fund, Ltd. (1702202) Filed by
Form SCHEDULE 13G/A
02/13/2026 3:41 PM
GeoVax Labs (832489) Subject
INTRACOASTAL CAPITAL, LLC (1646799) Filed by
Form SCHEDULE 13G/A
02/11/2026 9:05 AM
Ayrton Capital LLC (1698148) Filed by
GeoVax Labs (832489) Subject
Form SCHEDULE 13G
01/26/2026 7:23 AM
GeoVax Labs (832489) Filer
Form 424B5
01/12/2026 3:31 PM
GeoVax Labs (832489) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2025 3:35 PM
GeoVax Labs (832489) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2025 5:50 AM
GeoVax Labs (832489) Filer
Form 424B4
12/21/2025 11:15 PM
GeoVax Labs (832489) Filer
Form EFFECT
12/12/2025 4:26 PM
GeoVax Labs (832489) Filer
Form S-1
Registration statement under Securities Act of 1933  
11/13/2025 4:20 PM
GeoVax Labs (832489) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2025 4:16 PM
GeoVax Labs (832489) Filer
Form 424B3
11/13/2025 4:17 PM
GeoVax Labs (832489) Filer
Form 424B3
11/13/2025 4:18 PM
GeoVax Labs (832489) Filer
Form 424B3
11/13/2025 4:19 PM
GeoVax Labs (832489) Filer
Form 424B3
11/13/2025 3:03 PM
GeoVax Labs (832489) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2025 4:24 PM
GeoVax Labs (832489) Subject
INTRACOASTAL CAPITAL, LLC (1646799) Filed by
Form SCHEDULE 13G/A
11/07/2025 3:43 PM
GeoVax Labs (832489) Filer
Form 424B3
10/20/2025 8:11 AM
GeoVax Labs (832489) Issuer
SPENCER JOHN N JR (1270555) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2025 3:41 PM
GeoVax Labs (832489) Filer
Form S-1
Registration statement under Securities Act of 1933  
10/14/2025 3:29 PM
GeoVax Labs (832489) Filer
Form DEF 14A
I was right about SpaceX (Ad)

Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.tc pixel

See how to claim your stake in SpaceX before the public can
09/30/2025 3:43 PM
GeoVax Labs (832489) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2025 9:44 AM
GeoVax Labs (832489) Filer
Form 424B5
09/29/2025 3:48 PM
GeoVax Labs (832489) Subject
Nasdaq Stock Market LLC (1354457) Filed by
Form 25-NSE
09/19/2025 3:01 PM
GeoVax Labs (832489) Filer
Form 424B5
08/14/2025 8:18 PM
ARMISTICE CAPITAL, LLC (1601086) Filed by
GeoVax Labs (832489) Subject
Form SCHEDULE 13G/A
08/08/2025 2:13 PM
GeoVax Labs (832489) Issuer
McKee Kelly T. Jr. (1903889) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2025 4:02 PM
GeoVax Labs (832489) Subject
INTRACOASTAL CAPITAL, LLC (1646799) Filed by
Form SCHEDULE 13G
07/07/2025 3:30 PM
GeoVax Labs (832489) Subject
L1 Capital Global Opportunities Master Fund, Ltd. (1702202) Filed by
Form SCHEDULE 13G
07/02/2025 5:01 AM
GeoVax Labs (832489) Filer
Form 424B4
06/30/2025 11:15 PM
GeoVax Labs (832489) Filer
Form EFFECT
06/26/2025 4:29 PM
GeoVax Labs (832489) Filer
Form S-1/A
06/16/2025 3:38 PM
GeoVax Labs (832489) Filer
Form S-1
Registration statement under Securities Act of 1933  
06/06/2025 8:38 AM
GeoVax Labs (832489) Issuer
Reynolds Mark (1298237) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025 8:39 AM
GeoVax Labs (832489) Issuer
Sharkey John W. (1515991) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025 8:41 AM
GeoVax Labs (832489) Issuer
McKee Kelly T. Jr. (1903889) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025 8:42 AM
GeoVax Labs (832489) Issuer
NEWMAN MARK J (1242123) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025 8:45 AM
GeoVax Labs (832489) Issuer
SPENCER JOHN N JR (1270555) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025 8:46 AM
GeoVax Labs (832489) Issuer
Morgan Jayne (1959682) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025 8:48 AM
GeoVax Labs (832489) Issuer
MCNALLY ROBERT T (1049435) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025 8:49 AM
GeoVax Labs (832489) Issuer
Kollintzas Dean G (1378351) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025 8:50 AM
CHASE RANDAL D (1078784) Reporting
GeoVax Labs (832489) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025 8:51 AM
GeoVax Labs (832489) Issuer
Lemerond Nicole (1941712) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025 8:35 AM
DODD DAVID A (1193607) Reporting
GeoVax Labs (832489) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

GeoVax Labs SEC Filings - Frequently Asked Questions

GeoVax Labs (GOVX) has submitted 324+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

GeoVax Labs's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results.

The most recent filing was a Form 8-K submitted on May 19, 2026. This was a current report on a material business event.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:GOVX) was last updated on 5/20/2026 by MarketBeat.com Staff.
From Our Partners